« A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease ». One Health & Risk Management , vol. 4, nᵒ 4, septembre 2023, p. 19-26, https://doi.org/10.38045/ohrm.2023.4.02.